Patients with inflammatory bowel disease (IBD) prefer oral tablets over other modes of medicine administration. (2nd September 2021)
- Record Type:
- Journal Article
- Title:
- Patients with inflammatory bowel disease (IBD) prefer oral tablets over other modes of medicine administration. (2nd September 2021)
- Main Title:
- Patients with inflammatory bowel disease (IBD) prefer oral tablets over other modes of medicine administration
- Authors:
- Denesh, Deepa
Carbonell, Jenelyn
Kane, John S
Gracie, David
Selinger, Christian P. - Abstract:
- ABSTRACT: Objectives : With increasing treatment choices for inflammatory bowel disease (IBD), patients' preferences should be considered to limit non-adherence. We explored patients' preferences for route, form and frequency of medication administration, and factors influencing these choices. Methods : Patients rated acceptability of different forms of medication on 10-point Likert scales and preferences for highest acceptable frequency. Results : Of 298 patients significantly more found tablets (91%) to be highly acceptable compared to granules (64%), infusions (33%) and subcutaneous injections (34%; p < 0.0001). The acceptable frequency for tablets was considered as daily by 63.5% and several times daily by 32.3%. Participants preferred nurse delivered over self-administered injections (median score 8 vs 5, p < 0.0001) and hospital-based infusions over infusions at home (median score 7 vs 5, p = 0.001). Patients with previous or current anti-TNF exposure were more accepting of self-administered injections (50.5% vs 23.3% anti-TNF naive; p < 0.001), more accepting of home based infusions (43.7% vs 28.0%; p = 0.001) and more accepting of hospital-based infusions (57.2% vs 37.8%; p = 0.02). Conclusion : Most patients with IBD prefer tablets. Those patients who already experienced biological agents, had a high level of acceptance for subcutaneous and intravenous forms of medication.
- Is Part Of:
- Expert review of gastroenterology & hepatology. Volume 15:Number 9(2021)
- Journal:
- Expert review of gastroenterology & hepatology
- Issue:
- Volume 15:Number 9(2021)
- Issue Display:
- Volume 15, Issue 9 (2021)
- Year:
- 2021
- Volume:
- 15
- Issue:
- 9
- Issue Sort Value:
- 2021-0015-0009-0000
- Page Start:
- 1091
- Page End:
- 1096
- Publication Date:
- 2021-09-02
- Subjects:
- Ulcerative colitis -- Crohn's disease -- inflammatory bowel disease -- adherence -- medication
Gastroenterology -- Periodicals
Liver -- Diseases -- Periodicals
616.3 - Journal URLs:
- http://www.future-drugs.com/loi/egh ↗
https://www.tandfonline.com/toc/ierh20/current ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/17474124.2021.1898944 ↗
- Languages:
- English
- ISSNs:
- 1747-4124
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9830.067000
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store - Ingest File:
- 18509.xml